Cross-cultural adaptation and validation of ALS Functional Rating Scale-Revised in Portuguese language;Adaptação transcultural e validação da ALS Functional rating scale-revised para a língua Portuguesa

Arquivos de Neuro-Psiquiatria

Volumn 68, Issue 1, 2010, Pages 44-47

  Guedes, Keyte ^a   Pereira, Cecília ^a   Pavan, Karina ^a   Valério, Berenice Cataldo Oliveira ^a  

^a IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

Author keywords

Amyotrophic lateral sclerosis; Cross cultural comparison; Scales; Translating

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE REVISED; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; CORRELATION COEFFICIENT; CULTURAL FACTOR; FEMALE; FUNCTIONAL ASSESSMENT INVENTORY; HUMAN; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; LANGUAGE; MALE; PORTUGAL; PROSPECTIVE STUDY; RATING SCALE; REPRODUCIBILITY; TEST RETEST RELIABILITY; VALIDATION STUDY; BRAZIL; DISABILITY; MIDDLE AGED; PATHOPHYSIOLOGY; PUBLICATION; QUESTIONNAIRE; YOUNG ADULT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BRAZIL; CROSS-CULTURAL COMPARISON; CULTURAL CHARACTERISTICS; DISABILITY EVALUATION; FEMALE; HUMANS; LANGUAGE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TRANSLATIONS; YOUNG ADULT;

EID: 77950487903     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2010000100010     Document Type: Article

References (20)

1. Leight NP, Swash M, Iwasaki Y, et al. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004;5:84-98.
2. Neudert C, Wasner M, Borasio G. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliative Med 2004;7:551-557.
3. Shipe C, Zivkovic SA. Electrodiagnostic evaluation of motor neuron disorders. Am J Electroneurodiagnostic Technol 2004;44:30-36.
4. Kirby J, Halligan E, Baptista MJ, et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain 2005;128:1686-1706.
5. Cedarbaum JM, Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997;152(Suppl 1):S1-S9.
6. Moore DH, Miller RG, Wals Study Group, ALS CARE Study Group. ALSFRS as a measure of disease progression and survival. Amyotrophic Lateral Sclerosis Other Motor Neuron Disorders 2003;4:42-50.
7. Kauffmann P, Levy G, Montes J, et al. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. ALS 2007;8:42-46.
8. Mannino M, Cellura E, Grimaldi G, Volanti P, Piccoli F, La Bella V. Telephone follow-up for patients with amyotrophic lateral sclerosis. Eur J Neurol 2007;14: 79-84.
9. Cedarbaum J, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13-21.
10. Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci 2008;275:69-73.
11. Miano B, Stoddard GJ, Davis S, Bromberg MB. Inter-evaluator reliability of the ALS Functional Rating Scale. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004;5:235-239.
12. Brooks BR. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1:293-299.
13. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432.
14. Guillemin F. Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol 1995;24:61-63.
15. Beaton D, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000;25:3186-3191.
16. Hillemacher T, Grabel E, Tigges S, et al. Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004;5:245-249.
17. Trail M, Nelson ND, Van JN, Appel SH, Lai EC. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003;209:79-85.
18. Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). ALS 2006;7:247-251.
19. Kidney D, Alexander M, Corr B, O'Toole O, Hardiman O. Oropharyngeal dysphagia in amyotrophic lateral sclerosis: neurological and dysphagia specific rating scales. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004;5:150-153.
20. Voustianiouk A, Seidel G, Panchal J, et al. ALSFRS an APPEL ALS scores: discordance with disease progression. Muscle Nerve 2008;37:668-972.